8.3. Analysis.

Comparison 8 Ketoconazole (2‐26 weeks) versus griseofulvin (2 to 26 weeks) in Trichophyton infections; 12‐26 weeks follow‐up, Outcome 3 Secondary outcome: percentage of drop‐outs as a surrogate for participant adherence.

Comparison 8 Ketoconazole (2‐26 weeks) versus griseofulvin (2 to 26 weeks) in Trichophyton infections; 12‐26 weeks follow‐up, Outcome 3 Secondary outcome: percentage of drop‐outs as a surrogate for participant adherence.